Present at ESPID 2027 across a range of PID abstract topics.
Abstract Topics
- Antimicrobials
- Novel antimicrobial treatments
- Resistance
- Pharmacology
- New Treatment Approaches
- Antifungals
- Antivirals
- Antimicrobial Stewardship
- Public health and epidemiology
- Population studies and surveillance
- Modelling studies
- Vaccines
- Maternal Vaccines
- Passive Immunization
- Vaccine development (phase 1-2)
- Vaccine efficacy (phase 3) and effectiveness
- Vaccine safety (post licensure)
- Vaccine hesitancy
- Vaccine equity
- Immunology & compromised host
- Host-pathogen interaction
- Host response diagnostics and imaging
- Infections in oncology and HSCT
- Infections in primary immunodeficiencies
- Infections in solid organ transplants
- Fungal infections
- Vaccines in immunocompromised patients
- Infections in early life
- Congenital Infections
- Neonatal sepsis
- Perinatal infections
- Non-respiratory infections
- Gastrointestinal infections including Hepatitis
- Urogenital infections
- CNS infections
- Sepsis, systemic and multi-organ infections
- Skeletal infections
- Tropical/parasite infections & travel medicine
- Vector-borne
- Zoonosis
- Emerging infections
- Skin Infections
- STDs
- Respiratory infections
- Viral respiratory infections
- Bacterial pneumonia
- ENT infections
- Mycobacteria and retroviruses
- Tuberculosis and other mycobacterial infections
- HIV/AIDS
- Digital tools and machine learning
- Decision support tools
- Artificial intelligence in infectious diseases
- Telemedicine
- Diagnostics and Biomarkers
- Health associated infections
- Infection prevention and Control
- Microbiome
- Kawasaki and Inflammatory Syndromes
- Medical Education
- Environmental Impact on Infectious Diseases
- One Health and Sustainability
- Other